Adult Acute Myeloid Leukemia — Trials

Adult Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

374 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 64
Recruiting: 39
Ph III recruiting: 4
Growth YoY: —
Industry share: 17%
Top sponsor: City of Hope Medical Center
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07478991	Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)(VENP-A-QUI)	recruiting	Phase 3	376	PETHEMA FoundationOTHER	1	Sep 29, 2026	clinicaltrials
NCT06652438	Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML	recruiting	Phase 3	448	Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER	18	Sep 2, 2026